RecruitingPhase 4NCT06144125
Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery
Prothrombin Complex Concentrate and Fresh Frozen Plasma in Viscoelastic Test-based Goal-directed Bleeding Management in Cardiac Surgery
Sponsor
Konkuk University Medical Center
Enrollment
100 participants
Start Date
Mar 27, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
The primary endpoint of this study is the completion time of hemostasis treatment when administered Fresh frozen plasma (FFP) and frozen powder coagulation factor concentrate (PCC) in goal-directed bleeding management for cardiac surgery.
Eligibility
Min Age: 20 YearsMax Age: 75 Years
Inclusion Criteria1
- patients undergoing cardiac surgery
Exclusion Criteria3
- thrombocytopenia
- oral anti-coagulant
- anti platelet agents
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BIOLOGICALfresh frozen plasma
transfusion of fresh frozen plasma
BIOLOGICALprothrombin complex concentrate
prothrombin complex concentrate administration
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06144125
Related Trials
Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients
NCT063362131 location
Cardiac Biomarkers for the Quantification of Myocardial Damage After Cardiac Surgery
NCT060669705 locations
Frailty, Physical Capacity and Lung Function in Postoperative Cardiac Surgery Patients
NCT062473581 location
The Effects of 360-degree Virtual Reality on Pre-procedural Anxiety in Patients Awaiting Elective Cardiac Surgery Involving a Sternotomy
NCT060014891 location
CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting
NCT0500254352 locations